Market research
5M0B.F Medicover AB (publ)
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- 38.39
- Analyst target
- Not available
- Dividend yield
- 0.8%
- Beta
- 1.5
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- SE0009778848
- Market cap
- 3B
- P/E ratio
- 38.39
- Analyst target
- Not available
- Dividend yield
- 0.8%
- Beta
- 1.5
About
About Medicover AB (publ)
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 5M0B.F discussion.
5 years, 5 months ago
Medicover AB (publ) is currently in a long term uptrend where the price is trading 33.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.6.
Medicover AB (publ)'s total revenue rose by 29.6% to $298M since the same quarter in the previous year.
Its net income has increased by 180.0% to $18M since the same quarter in the previous year.
Finally, its free cash flow grew by 2800.0% to $8M since the same quarter in the previous year.
Based on the above factors, Medicover AB (publ) gets an overall score of 5/5.